Hepatocellulært karsinom
Sist oppdatert: Sist revidert:
Sist revidert av:Terje Johannessen
Definisjon:
Er en primær leverkreftsykdom som utgår fra hepatocytter, vanligvis i forløpet av en kronisk leversykdom, særlig virushepatitt
Forekomst:
Lav forekomst i Norge fordi insidensen av hepatitt er lav
Symptomer:
Pasientene har som regel symptomer fra den underliggende kroniske leversykdommen og man blir oppmerksom på tilstanden ved rask forverring
Funn:
Tegn på den tilgrunnliggende sykdommen, cirrhose/leversvikt, forekommer i form av spenomegali, ascites, ikterus, spider nevi, gynekomasti
Diagnostikk:
Tilleggsundersøkelser viser forhøyet ALAT, ALP, GT, bilirubin og lav NT, albumin, trombocytter, ev. alfaføtoprotein. Bildediagnostikk + biopsi
Behandling:
Kirurgisk fjerning av svulster, leverreseksjon, er vanligvis nytteløst dersom cirrhose er tilstede og svulsten er stor eller multifokal. Ev. levertransplantasjon
- Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012; 379:1245. PubMed
- Schwartz JM, Carithers RL, Sirlin CB. Clinical features and diagnosis of primary hepatocellular carcinoma. UpToDate, last updated Mar 29, 2021. UpToDate
- Cicalese L. Hepatocellular carcinoma. Medscape, last updated May 03, 2017. emedicine.medscape.com
- Vogel A, Cervantes A, Chau I, et al. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 2018; 29 (Suppl._4): iv238–iv255. www.esmo.org
- Schwartz JM, Carithers RL. Epidemiology and risk factors for hepatocellular carcinoma. UpToDate, last updated Oct 13, 2020. www.uptodate.com
- Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61:69. PubMed
- Ryerson AB, Eheman CR, Altekruse SF, et al. Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer. Cancer 2016; 122:1312. PubMed
- Kreftregisteret. Cancer in Norway 2020. Oslo, 2021: www.kreftregisteret.no.
- Bugianesi E. Non-alcoholic steatohepatitis and cancer. Clin Liver Dis. 2007 Feb. 11(1):191-207, x-xi.
- Yatsuji S, Hashimoto E, Tobari M et al. Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C. J Gastroenterol Hepatol 2009; 24: 248–254. PMID: 19032450 PubMed
- Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65-73. Journal of the American Medical Association
- Yu NC, Chaudhari V, Raman SS, et al. CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis. Clin Gastroenterol Hepatol 2011; 9:161. PubMed
- Crippin JS. Biopsy of suspicious liver nodules: does it change management?. Clin Gastroenterol Hepatol 2006; 4: 361. PubMed
- Abdalla EK, Stuart KE. Overview of treatment approaches for hepatocellular carcinoma. UpToDate, last updated Nov 29, 2021. UpToDate
- Llovet JM, Mazzaferro V, Hilgard P, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359:378-90. doi:10.1056/NEJMoa0708857 DOI
- Taefi A, Abrishami A, Nasseri-Moghaddam S, Eghtesad B, Sherman M. Surgical resection versus liver transplant for patients with hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD006935. DOI: 10.1002/14651858.CD006935.pub2. DOI
- Awad T, Thorlund K, Gluud C. Cryotherapy for hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD007611. DOI: 10.1002/14651858.CD007611.pub2. DOI
- Zhong JH, Li LQ, Wu LC. Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2011, Issue 12. Art. No.: CD008713. DOI: 10.1002/14651858.CD008713.pub2. DOI
- Oliveri RS, Wetterslev J, Gluud C. Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2011, Issue 3. Art. No.: CD004787. DOI: 10.1002/14651858.CD004787.pub2. DOI
- Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208. PubMed
- Terje Johannessen, professor i allmennmedisin, Trondheim
Tidligere fagmedarbeidere
- Lars Aabakken, førsteamanuensis ved Universitetet i Oslo, lege ved Medisinsk avdeling, Rikshospitalet